NCT05070702View on ClinicalTrials.gov

First in Human Study of CT-1500 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

November 8, 2021

Primary Completion Date

July 7, 2022

Study Completion Date

July 7, 2022

Conditions
Healthy
Interventions
DRUG

CT-1500

Hard Capsule

DRUG

Placebo

Hard Capsule

Trial Locations (1)

3004

Nucleus Network, Melbourne

Sponsors
All Listed Sponsors
collaborator

Neuroscience Trials Australia

OTHER

lead

Circadian Therapeutics Ltd

INDUSTRY

NCT05070702 - First in Human Study of CT-1500 in Healthy Participants | Biotech Hunter | Biotech Hunter